Results 171 to 180 of about 379,930 (351)
Kunlun Li,1 Yuqing Jiang,1 Delun Li,2 Jianguang Sun1 1Department of Orthopaedics, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China; 2Data Center, Meizhou People’s Hospital, Meizhou Academy of Medical ...
Li K, Jiang Y, Li D, Sun J
doaj
The organic nanozyme IR‐IHpd, which has NIR‐PDT and POD‐like activity, is designed for continuous ROS generation. It is co‐encapsulated with CB‐839 and coated with DC membranes to simultaneously target tumors and T cells. Under NIR irradiation, immunogenic cell death is activated. Concurrently, CB‐839 suppresses ammonia‐induced T lymphocyte death (AITD)
Meng Suo +7 more
wiley +1 more source
Metabolic reprogramming in bone metastasis of human cancers. [PDF]
Li T, Wang Z, Yang H, Kang Y.
europepmc +1 more source
Breast cancer reprograms the lung into a receptive pre‐metastatic niche via a novel G‐CSF–VEGFA–KDR signaling axis. Using a micro‐organ chip that enables contact‐independent coculture, this study uncovers how tumor‐secreted G‐CSF activates lung capillary KDR to drive angiogenesis and prime the soil for metastasis—without direct tumor contact.
Jingxin Zhang +12 more
wiley +1 more source
A scoring system for screening of patients with synchronous bone metastasis in lung cancer. [PDF]
Zhao W +9 more
europepmc +1 more source
Three-Dimensional In Vitro Hydro- and Cryogel-Based Cell-Culture Models for the Study of Breast-Cancer Metastasis to Bone [PDF]
Laura J. Bray +6 more
openalex +1 more source
Advanced Therapeutic Approach Based on LDHs–Mimetic Oxidoreductase
Overview of Sructure, Multienzyme‐mimicking Activity and Advanced Therapeutic Approach Based on LDHs–Mimetic Oxidoreductase. Abstract Redox dysregulation is recognized as a key driver in the pathophysiology of numerous refractory diseases, contributing significantly to the progression and poor prognosis.
Kai Song +9 more
wiley +1 more source
Pan-cancer bone metastasis atlas at single-cell resolution identifies a distinct tumor-associated macrophage subset for mediating Denosumab-induced immunosensitization in lung cancer bone metastasis. [PDF]
Hu X +19 more
europepmc +1 more source

